THE PROGNOSIS OF THE RESULTS OF DOUBLE-COMPONENT ANTIHYPERTENSIONAL THERAPY ACCOUNTING MEANINGS OF MIDDLE DAILY HEART RATE AND NON-MODIFIED RISK FACTORS

  • N.I. Yabluchansky
  • H.G. Datsenko
Keywords: essential arterial hypertension, , risk factors, heart rate, enalaprili maleatum, hydrochlirtiasidum

Abstract

In the grounds of complex examination of 300 patients with essential arterial hypertension the mathematical pattern of prognosis the results of double-component antihypertention therapy by enalaprili maleatum (10 mg per day) and hydrochlortiasidum (25 mg per day) was worked out. Accounted the initial meanings of middle daily heart rate (HR) non-modified risk factors (the blood pressure (BP) level, the type of somato-vagal balance and the type of left ventricular geometry). It was started, that good results of  lowering BP in the double-component antihypertentional therapy by enalaprili maleatum (10 mg per day) and hydrochlortiasidum (25 mg per day) correspond the probabily of 70%, setisfed results of normalisation - the probabily of 50-70%, dissetistole results - the probabily of less then 50%. The  double-component antihypertentional therapy by enalaprili maleatum (10 mg per day) and hydrochlortiasidum (25 mg per day) is shown to the patients with the probability of BP normalization more than 70%. 

Downloads

Download data is not yet available.

References

1. Дзяк Г. В., Васильева Л. И., Ханюков А. А, Артериальная гипертензия. Принципы и тактика лече-ния. Днепропетровск: Арт-Пресс, 2000. 52с.

2. Кобалава Ж.Д., Котовская Ю.В. Артериальная гипертония 2000. М.: Медицина, 2001. 198 с.

3. Свіщенко Е.П., Коваленко В.Н. Артериальная гипертензия. Практическое руководство. -К.: МОРІОН, 2001. 528 с.

4. Сіренко Ю. М. Артеріальна гіпертензія. 2002. 2-ге вид., доп. -К.: МОРІОН, 2002. 204 с.

5. Сіренко Ю.М., Рековець В.М., Гур’єва О.С. Артеріальна гіпертензія: сучасні аспекти контролю антигіпертензивної терапії (частина 2). // Український кардіологічний журнал. 2002. № 6. С.88-96.

6. Яблучанский Н.И., Исаева А. С., Мартыненко А. В. Основы практического применения неинва-зивной технологии исследования регуляторных систем человека. -Харьков: “Основа “. 2000. 88 с.

7. Agence Nationale d’Accreditation et d’Evaluation en Sante Recommandations (АNAES ), 2000. 117 p.

8. Chalmers J. // Clinical and Experimental Hypertension. 1999. Vol. 21. P. 875–884.

9. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guide-lines for the management of arterial hypertension. // J. Hypertension. 2003. Vol. 21. P. 1011-1053.

10. Kalpan N.M. // Journal of Hypertension. 1999. Vol. 13. P. 707–710.

11. Korner I.P., Lennings C. // Journal of Hypertension. 1998. Vol. 16. P. 715-723.

12. Sica D.A., Ripley E. Low–Dose Fixed–Combination Antihypertensive Therapy in Hypertension a com-panion to the Brenner and Rectors’ The Kidney. Saunders Company. 2000. Р. 497–504.
How to Cite
Yabluchansky, N., & Datsenko, H. (1). THE PROGNOSIS OF THE RESULTS OF DOUBLE-COMPONENT ANTIHYPERTENSIONAL THERAPY ACCOUNTING MEANINGS OF MIDDLE DAILY HEART RATE AND NON-MODIFIED RISK FACTORS. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (7), 101-107. Retrieved from https://periodicals.karazin.ua/medicine/article/view/7269
Section
Clinical research

Most read articles by the same author(s)